The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose escalation of cabozantinib as a viable option for the treatment of mRCC.
 
Martin Boegemann
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Roche; Sanofi
 
Laura-Maria Krabbe
No Relationships to Disclose
 
Andres Jan Schrader
No Relationships to Disclose
 
Axel Semjonow
No Relationships to Disclose
 
Yvonne Klaile
Travel, Accommodations, Expenses - Ipsen
 
Katrin Schlack
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen